Depression and coronary heart disease: A review of the epidemiological evidence, explanatory mechanisms and management approaches

Clinical Psychology Review

Volumn 28, Issue 2, 2008, Pages 288-306

  Goldston, Kerrie ^a,b   Baillie, Andrew J ^b  

^a NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Antidepressant drugs; Cognitive behavior therapy; Coronary heart disease; Depression; Epidemiology; Evidence based psychology

Indexed keywords

CARDIOVASCULAR RISK; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALTH PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW;

EID: 38649104481     PISSN: 02727358     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpr.2007.05.005     Document Type: Review

References (106)

1. Alexopoulos G.S., Meyer B.S., Youn R.C., Campbel S., Silberswei D., and Charlso M. 'Vascular Depression' hypothesis. Archives of General Psychiatry 54 10 (1997) 915-922
2. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 36 (2000) 959-969
3. Alvarez W., and Pickworth K.K. Safety of antidepressant drugs in the patient with cardiac disease: A review of the literature. Pharmacotherapy 23 6 (2003) 754-771
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IV-TR Ed.) (2004), American Psychiatric Press, Arlington, VA
5. Anda R.F., Williamson D.F., Excobedo L.G., Mast E.E., Giovino G.A., and Remington P.L. Depression and the dynamics of smoking: A national perspective. Journal of the American Medical Association 264 (1990) 1546-1549
6. Anisman H., and Merali Z. Cytokines, stress, and depressive illness. Brain, Behavior, and Immunity 16 (2002) 513-524
7. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., and Hand M. American college of cardiology/American heart association guidelines for the management of ST-elevation myocardial infarction. Circulation 110 (2004) 82-292
8. Babyak M.A., Blumenthal J.A., Herman S., Khatri P., Doraiswamy M., and Moore K. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine 62 (2000) 633-638
9. Balough S., Fitzpatrick D.F., Hendricks S.E., and Paige S.R. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacology Bulletin 29 (1993) 201-206
10. Banki C.M., Karmacsi L., Bissette G., and Nemeroff C.B. CSF corticotropin releasing and somatostatin in major depression: Response to antidepressant treatment and relapse. European Neuropsychopharmacology 2 (1992) 107-113
11. Barth J., Schumacher M., and Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomatic Medicine 66 (2004) 802-813
12. Beck A.T., and Steer R.A. Manual for the revised Beck depression inventory (1987), The Psychological Corporation, San Antonio, Texas
13. Berkman L.F. The role of social relations in health promotion. Psychosomatic Medicine 57 (1995) 245-254
14. Berkman L.F., Leo-Summers L., and Horwitz R.I. Emotional support and survival after myocardial infarction: A prospective, population-based study of the elderly. Annals of Internal Medicine 15 117 (1992) 1003-1009
15. Blumenthal J.A., Babyak M.A., Moore K.A., Craighead W.E., Herman S., Khatri P., et al. Effects of exercise training on older patients with major depression. Archives of Internal Medicine 159 (1999) 2349-2356
16. Blumenthal J.A., Sherwood A., Babyak M.A., Watkins L.I., Waugh R., and Georgiades A. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischaemic heart disease: A randomized controlled trial. Journal of the American Medical Association 293 13 (2005) 1626-1634
17. Broadley A.J., Korazun A., Jones C.J., and Frenneaux M.P. Arterial endothelial function is impaired in treated depression. Heart 88 (2002) 521-523
18. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: Does cortisol play a role?. Biological Psychiatry 55 1 (2004) 1-9
19. Bunker S.T., Colquoun D.M., Murray E.D., Hickie I.B., Hunt D., Jelinek M.V., et al. "Stress" and coronary heart disease: Psychosocial risk factors. National Heart Association of Australia position statement update. Medical Journal of Australia 178 6 (2003) 272-276
20. Butcher J.N., Dahlstrom W.G., Graham J.R., Tellegen A., and Kaemmer B. MMPI-2: Manual for administration and scoring (1989), University of Minnesota Press, Minneapolis
21. Carney R.M., Blumenthal J.A., Freedland K.E., Youngblood M., Veith R.C., Burg M.M., et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosomatic Medicine 66 (2004) 466-474
22. Carney R.M., Blumenthal J.A., Stein P.K., Watkins L., Catellier D., Berkman L.F., et al. Depression, heart rate variability and acute myocardial infarction. Circulation 104 (2001) 2024-2028
23. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., and Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology 14 1 (1995) 88-90
24. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., and Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine 62 (2000) 639-647
25. Carney R.M., Freedland K.E., Veith R.C., Cryer P.E., Skala J.A., Lynch T., et al. Major depression, heart rate and plasma norepinephrine in patients with coronary heart disease. Society of Biological Psychiatry 45 (1999) 458-463
26. Carney R.M., Rich M.W., Revelled A., Saine J., Clark K., and Jaffe A.S. Major depressive disorder in coronary artery disease. American Journal of Cardiology 60 (1987) 1273-1275
27. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.E., et al. A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility. Archives of General Psychiatry 38 (1981) 15-22
28. Case R.B., Moss A.J., Case N., McDermott M., and Eberley S. Living alone after myocardial infarction. Journal of the American Medical Association 267 (1992) 515-519
29. Cohen H.W., Gibson G., and Alderman N.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. American Journal of Medicine 108 1 (2000) 2-8
30. Craighead W.E., Hart A.B., Craighead I.W., and Ilardi S.S. Psychosocial treatments for major depressive disorder. In: Nathan P., and Gorman J.M. (Eds). A guide to treatments that work. (2002), Oxford University Press, New York
31. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for non-compliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine. 160 (2000) 2101-2107
32. Doraiswamy P.M., MacFall J., Krishnan K.R., O'Connor C., Wan X., Benaur M., et al. Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: Preliminary findings. American Journal of Psychiatry 156 (1999) 1641-1643
33. Dusseldorp E., van Elderen T., Maes S., Meulman J., and Draaij V. A meta-analysis of psycho-educational programs for coronary heart disease patients. Health Psychology 18 (1999) 506-519
34. First M.B., Gibbon M., Spitzer R.L., and Williams J.B.W. User's guide for the structured clinical interview for DSM-IV axis I disorders - Clinician version (SCID-CV) (1997), American Psychiatric Press, Washington, DC
35. Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. American Journal of Cardiology 15 67 (1991) 121-127
36. Frasure-Smith N., Lesperance F., Gravel G., Masson A., Juneau M., Talajic M., et al. Social support, depression and mortality during the first year after myocardial infarction. Circulation 101 (2000) 1919-1924
37. Frasure-Smith N., Lesperance F., Prince R.H., Verrier P., Garber R.A., Juneau M.S., et al. Randomised trial of home-based psychological nursing intervention for patients recovering from myocardial infarction. Lancet 350 (1997) 463-479
38. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., et al. Smoking, smoking cessation and major depression. Journal of the American Medical Association 264 (1990) 1546-1549
39. Glassman A.H., O'Connor C.M., Califf R., Swedberg K., Schwatz P., Bigger Jr. J.T., et al. Sertraline treatment of major depression in patients with acute myocardial infarction or unstable angina. Journal of the American Medical Association 288 6 (2002) 701-709
40. Glassman A.H., and Shapiro P.A. Depression and the course of coronary artery disease. American Journal of Psychiatry 155 1 (1997) 4-11
41. Gorkin L., Schron E.B., Brooks M.M., Wiklund I., Keller J., Verter J., et al. Psychosocial predictors of mortality in the cardiac arrhythmia suppression trial-1 (CAST-1). American Journal of Cardiology 71 (1993) 263-267
42. Gorman J.M., and Sloan R.P. Heart rate variability in depression and anxiety disorders. American Heart Journal 140 Suppl.4 (2000) 77-83
43. Hill A.B. The environment and disease: Association or causation?. Proceedings of the Royal Society of Medicine 58 (1965) 295-300
44. Horsten M., Wamala S.P., Vingerhoets A., and Orth-Gomer K. Depressive symptoms, social support and lipid profile in healthy middle-aged women. Psychosomatic Medicine 59 (1997) 521-528
45. Jiang W., Krishnan R.K., and O'Connor C.M. Depression and heart disease: Evidence of a link and its therapeutic implications. CNS Drugs 16 2 (2002) 111-127
46. Jones D.A., and West R.R. Psychological rehabilitation after myocardial infarction: Multicentre randomised controlled trial. British Medical Journal 313 (1996) 1517-1521
47. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry 55 (1998) 694-700
48. Khaykin Y., Dorian P., Baker B., Shapiro C., Sandor P., Mironov D., et al. Autonomic correlates of antidepressant treatment using heart rate variability analysis. Canadian Journal of Psychiatry 43 (1998) 183-186
49. Krantz D.S., and McConey M.K. Effect of psychological and social factors on organic disease: A critical assessment of the research on coronary heart disease. Annual Review of Psychology 53 (2002) 341-369
50. Krishnan K.R., George L.K., Pieper C.F., Jiang W., Arias R., Look A., et al. Depression and social support in elderly patients with cardiac disease. American Heart Journal 136 (1998) 491-495
51. Krishnan K.R., Hays J.C., and Blazer D.G. MRI-defined vascular depression. American Journal of Psychiatry 154 (1997) 497-501
52. Kubzansky L., and Kawachi I. Going to the heart of the matter: Do negative emotions cause coronary heart disease?. Journal of Psychosomatic Research 48 (2000) 323-337
53. Kugler J., Seelbach H., and Krueskemper G.M. Effects of rehabilitation exercise programs on anxiety and depression in coronary patients. British Journal of Clinical Psychology 33 (1994) 401-410
54. Kuper H., Marmot M., and Hemingway H. Systematic review of prospective cohort studies of psychosocial factors in the aetiology and prognosis of coronary heart disease. Seminars in Cardiovascular Medicine 2 3 (2002) 267-313
55. Laghrissi-Thode F., Wagner W., Polloci B., Johnson P.C., and Finkel M.S. Elevated platelet factor-4 and b-thromoboglobulin plasma levels in depressed patients with ischaemic heart disease. Biological Psychiatry 42 (1997) 290-295
56. Lawler D.A., and Hopker S.W. The effectiveness of exercise as an intervention in the management of depression: Systematic review and meta-regression analysis of randomised controlled trails. British Medical Journal 322 (2001) 763-767
57. Lees K., Bennett P., West R., Davey S.G., and Ebrahim S. Psychological interventions for coronary heart disease. The Cochrane Database of Systematic reviews, 3, Art. No: CD002902. (2004) DOI:002910.001002/14651858.CD14002902.pub14651852
58. Lesperance F., and Frasure-Smith N. Depression in patients with cardiac disease: A practical review. Journal of Psychosomatic Research 48 (2000) 379-391
59. Lesperance F., Frasure-Smith N., and Talajic M. Major depression before and after myocardial infarction: Its nature and consequences. Psychosomatic Medicine 58 (1996) 99-110
60. Lett H., Blumenthal J.A., Babyak M.A., Sherwood A., Strauman T., Robins C., et al. Depression as a risk factor for coronary artery disease: Evidence, mechanisms and treatment. Psychosomatic Medicine 66 (2004) 305-315
61. Linden W., Stossel C., and Maurice J. Psychosocial interventions for patients with coronary artery disease: A meta-analysis. Archives of Internal Medicine 156 (1996) 745-752
62. McFarlane A., Kamath M.V., Fallen E.L., Malcolm V., Cherian F., and Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. American Heart Journal 142 (2001) 617-623
63. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., Banks W.A., et al. Clinical depression and inflammatory risk markers for coronary heart disease. American Journal of Cardiology 90 (2002) 1279-1283
64. Monster T.B., Johnsen S.P., Olsen M.L., McLaughlin J.K., and Sorensen H.T. Antidepressants and risk of first-time hospitalization for myocardial infarction: A population-based case-control study. American Journal of Medicine 117 (2004) 732-737
65. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: Epidemiology, biology and treatment. Archives of General Psychiatry 55 (1998) 580-592
66. Musselman D.L., Marzec U.M., Manatunga A., Penna S., Reemsnyder A., Knight B.T., et al. Platelet reactivity in depressed patients treated with Paroxetine: Preliminary findings. Archives of General Psychiatry 57 (2000) 872-875
67. Musselman D.L., and Nemeroff C.B. Depression and endocrine disorders: Focus on the thyroid and adrenal system. British Journal of Psychiatry Suppl 30 (1996) 123-128
68. Musselman D.L., Tomer A., Manatunga A.K., Knight B.T., Porter M.R., Kasey S., et al. Exaggerated platelet reactivity in major depression. American Journal of Psychiatry 153 10 (1996) 1313-1317
69. National Heart Foundation of Australia, and The Cardiac Society of Australia and New Zealand. Management of unstable angina guidelines - 2000. Medical Journal of Australia 173 (2000) S65-S88 (Supplement)
70. National Heart Foundation of Australia, and Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: Guidelines for reducing risk in patients with coronary heart disease (2003), National Heart Foundation of Australia, Canberra
71. Nemeroff C.B., Widerlov E., Bissette G., Walleous H., Karlsson I., Eklund K., et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1344
72. Paffenbarger R.S., Kampert J.B., Lee I.M., Hyde R.T., Leung R.W., and Wing A.L. Changes in physical activity and other life way patterns influencing longevity. Medical Science and Sports Exercise 26 7 (1994) 857-865
73. Pincus H.A., Davis W.W., and McQueen L.E. "Subthreshold" mental disorders: A review and synthesis of studies on minor depression and other "brand names". British Journal of Psychiatry 174 (1999) 288-296
74. Pitzalis M.V., Iacoviello M., Todarello O., Pioretta A., Guida P., Massari S., et al. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. American Heart Journal 141 (2001) 765-771
75. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
76. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., and Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. American Journal of Cardiology 88 (2001) 196-198
77. Robins L.N., Cottler L., Bucholz K., and Compton W. The diagnostic interview schedule, version-IV (1995), Washington University School of Medicine, St Louis, MO
78. Roose S.P., and Spatz E. Treatment of depression in patients with heart disease. Journal of Clinical Psychiatry 60 Suppl. 20 (1999) 34-37
79. Rosengren A., Hawken S., Ounpuu S., Sliwa K., Zubaid M., Almahmeed W.A., et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 364 (2004) 953-962
80. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioural cardiology. Journal of the American College of Cardiology 45 5 (2005) 637-651
81. Rozanski A., Blumenthal J.A., and Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999) 2192-2217
82. Ruberman W., Weinblatt E., Goldberg J., and Choudary B.S. Psychosocial influences on mortality after myocardial infarction: A prospective, population-based study of the elderly. Annals of Internal Medicine 117 (1984) 1003-1009
83. Rugulies R. Depression as a predictor for coronary heart disease: A review and meta-analysis. American Journal of Preventive Medicine 23 1 (2002) 51-61
84. Sauer W.H., Berlin J.A., and Kimmel S.E. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108 (2001) 32-36
85. Sauer W.H., Berlin J.A., and Kimmel S.E. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104 (2003) 1894-1898
86. Schins A., Honig A., Crijins J., Baur L., and Hamulak K. Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?. Psychosomatic Medicine 65 5 (2003) 729-737
87. Schrader G., Cheok F., Hordacre A., Marker J., and Wade V. Effect of psychiatry liaison with general practitioners on depression severity in recently hospitalised cardiac patients: A randomised controlled trial. Medical Journal of Australia 182 6 (2005) 272-276
88. Serebruany V.L., O'Connor C.M., and Gurbel P.A. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. American Journal of Cardiology 87 (2001) 1398-1400
89. Skop B.P., and Brown T.M. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37 (1996) 12-16
90. Stein P.K., Carney R.M., Freedland K.E., Skala J.A., Jaffe A.S., Kleiger R.E., et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. Journal of Psychosomatic Research 48 (2000) 493-500
91. Strawbridge W.J., Deleger S., Roberts R.E., and Kaplan G.A. Physical activity reduces the risk of subsequent depression for older adults. American Journal of Epidemiology 156 (2002) 328-334
92. Strik J.J., Honig A., Lousberg R., Cheriex E.C., and Van Pragg H.M. Cardiac side effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients. International Clinical Psychopharmacology 13 6 (1998) 263-267
93. Strik J.J., Honig A., Lousberg R., Lousberg A.H., Cheriex E.C., and Tuynman-Qua H.G. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine 62 6 (2000) 783-789
94. Suazrez E.C., Krishnan R.R., and Lewis J.G. The relation of severity of depressive symptoms to moncyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosomatic Medicine 65 3 (2003) 362-368
95. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., and Burg M.M. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Archives of General Psychiatry 62 7 (2005) 792-798
96. Taylor D.K., Barber K.R., and McIntosh B.A. The impact of post-acute myocardial infarction (AMI) depression on patient compliance and risk factor modification. Psychology Health & Medicine 3 (1998) 439-442
97. The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. Journal of the American Medical Association 289 (2003) 3106-3116
98. Todaro J.F., Shen B.-J., Niaura R., and Tilkemeier P.L. Prevalence of depressive disorders in men and women enrolled in cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation 25 (2005) 71-75
99. Van Melle J.P., Jonge P., Spukerman T.A., Tussen J.G., Ormel J., and Dirk J. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomatic Medicine 66 (2004) 814-822
100. Wang P.S., Bohn R.L., Knight E., Glynn R.J., Mogun H., and Avorn J. Non-compliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine 17 (2002) 504-511
101. Welin C., Lappas G., and Wilhelmsen I. Independent importance of psychological factors for prognosis after myocardial infarction. Journal of Internal Medicine 247 (2000) 629-639
102. Williams R.B., Barefoot J.C., Califf R.M., L. H.T., Saunders W.B., Pryor D.B., et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. Journal of the American Medical Association 267 (1992) 520-524
103. Williams J.W., Pignone M., Ramirez G., and Perez Stellato C. Identifying depression in primary care: A literature synthesis of case-finding instruments. General Hospital Psychiatry 24 4 (2002) 225-237
104. Wulsin L.R., and Singal B.M. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine 65 2 (2003) 201-210
105. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., Romanelli J., Richter D.P., Bush D.E., et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of Internal Medicine 160 (2000) 1818-1823
106. Zung W.W.K. A self-rating depression scale. Archives of General Psychiatry 12 (1965) 63-70